nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Venous thrombosis—Carboplatin—bone cancer	0.0561	0.0561	CcSEcCtD
Sodium lauryl sulfate—Fluid overload—Carboplatin—bone cancer	0.0487	0.0487	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Carboplatin—bone cancer	0.0347	0.0347	CcSEcCtD
Sodium lauryl sulfate—Tetany—Cisplatin—bone cancer	0.0273	0.0273	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Carboplatin—bone cancer	0.0255	0.0255	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Cisplatin—bone cancer	0.0165	0.0165	CcSEcCtD
Sodium lauryl sulfate—Faecaloma—Epirubicin—bone cancer	0.016	0.016	CcSEcCtD
Sodium lauryl sulfate—Faecalith—Epirubicin—bone cancer	0.016	0.016	CcSEcCtD
Sodium lauryl sulfate—Faecaloma—Doxorubicin—bone cancer	0.0148	0.0148	CcSEcCtD
Sodium lauryl sulfate—Faecalith—Doxorubicin—bone cancer	0.0148	0.0148	CcSEcCtD
Sodium lauryl sulfate—Warmth—Epirubicin—bone cancer	0.0143	0.0143	CcSEcCtD
Sodium lauryl sulfate—Fluid overload—Cisplatin—bone cancer	0.0143	0.0143	CcSEcCtD
Sodium lauryl sulfate—Hyperphosphataemia—Epirubicin—bone cancer	0.0134	0.0134	CcSEcCtD
Sodium lauryl sulfate—Warmth—Doxorubicin—bone cancer	0.0133	0.0133	CcSEcCtD
Sodium lauryl sulfate—Hyperphosphataemia—Doxorubicin—bone cancer	0.0124	0.0124	CcSEcCtD
Sodium lauryl sulfate—Intestinal perforation—Methotrexate—bone cancer	0.0123	0.0123	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Cisplatin—bone cancer	0.0113	0.0113	CcSEcCtD
Sodium lauryl sulfate—Abscess—Cisplatin—bone cancer	0.0112	0.0112	CcSEcCtD
Sodium lauryl sulfate—Infection—Carboplatin—bone cancer	0.0107	0.0107	CcSEcCtD
Sodium lauryl sulfate—Tenderness—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Cisplatin—bone cancer	0.00977	0.00977	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Cisplatin—bone cancer	0.00939	0.00939	CcSEcCtD
Sodium lauryl sulfate—Hypernatraemia—Epirubicin—bone cancer	0.00868	0.00868	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Carboplatin—bone cancer	0.00854	0.00854	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Epirubicin—bone cancer	0.00845	0.00845	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Cisplatin—bone cancer	0.00843	0.00843	CcSEcCtD
Sodium lauryl sulfate—Hypernatraemia—Doxorubicin—bone cancer	0.00803	0.00803	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Doxorubicin—bone cancer	0.00782	0.00782	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Cisplatin—bone cancer	0.00749	0.00749	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Cisplatin—bone cancer	0.00711	0.00711	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Cisplatin—bone cancer	0.00699	0.00699	CcSEcCtD
Sodium lauryl sulfate—Cyanosis—Methotrexate—bone cancer	0.00689	0.00689	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Cisplatin—bone cancer	0.00658	0.00658	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Methotrexate—bone cancer	0.00621	0.00621	CcSEcCtD
Sodium lauryl sulfate—Abscess—Methotrexate—bone cancer	0.00616	0.00616	CcSEcCtD
Sodium lauryl sulfate—Irritability—Cisplatin—bone cancer	0.00616	0.00616	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Cisplatin—bone cancer	0.00604	0.00604	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Cisplatin—bone cancer	0.006	0.006	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Cisplatin—bone cancer	0.00587	0.00587	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Epirubicin—bone cancer	0.00581	0.00581	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Epirubicin—bone cancer	0.00581	0.00581	CcSEcCtD
Sodium lauryl sulfate—Abscess—Epirubicin—bone cancer	0.00577	0.00577	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Methotrexate—bone cancer	0.00559	0.00559	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Cisplatin—bone cancer	0.00543	0.00543	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Doxorubicin—bone cancer	0.00538	0.00538	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Doxorubicin—bone cancer	0.00538	0.00538	CcSEcCtD
Sodium lauryl sulfate—Abscess—Doxorubicin—bone cancer	0.00534	0.00534	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Methotrexate—bone cancer	0.00529	0.00529	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Epirubicin—bone cancer	0.00523	0.00523	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Methotrexate—bone cancer	0.00515	0.00515	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Epirubicin—bone cancer	0.00502	0.00502	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Epirubicin—bone cancer	0.00498	0.00498	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Epirubicin—bone cancer	0.00495	0.00495	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Cisplatin—bone cancer	0.0049	0.0049	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Cisplatin—bone cancer	0.00489	0.00489	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Cisplatin—bone cancer	0.00487	0.00487	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Doxorubicin—bone cancer	0.00484	0.00484	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Epirubicin—bone cancer	0.00482	0.00482	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Epirubicin—bone cancer	0.00479	0.00479	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Doxorubicin—bone cancer	0.00464	0.00464	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Doxorubicin—bone cancer	0.00461	0.00461	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Doxorubicin—bone cancer	0.00458	0.00458	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Doxorubicin—bone cancer	0.00446	0.00446	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Doxorubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Epirubicin—bone cancer	0.00433	0.00433	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Epirubicin—bone cancer	0.00431	0.00431	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Methotrexate—bone cancer	0.00423	0.00423	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Doxorubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Cisplatin—bone cancer	0.00399	0.00399	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Doxorubicin—bone cancer	0.00399	0.00399	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Epirubicin—bone cancer	0.00396	0.00396	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Epirubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Methotrexate—bone cancer	0.00383	0.00383	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Cisplatin—bone cancer	0.00383	0.00383	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Doxorubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Cisplatin—bone cancer	0.00366	0.00366	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Epirubicin—bone cancer	0.00365	0.00365	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Methotrexate—bone cancer	0.00361	0.00361	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Epirubicin—bone cancer	0.00359	0.00359	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Doxorubicin—bone cancer	0.00356	0.00356	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Epirubicin—bone cancer	0.00348	0.00348	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Epirubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Doxorubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Sodium lauryl sulfate—Irritability—Methotrexate—bone cancer	0.00338	0.00338	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Cisplatin—bone cancer	0.00337	0.00337	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Doxorubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Cisplatin—bone cancer	0.0033	0.0033	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Doxorubicin—bone cancer	0.00322	0.00322	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Cisplatin—bone cancer	0.00317	0.00317	CcSEcCtD
Sodium lauryl sulfate—Oedema—Cisplatin—bone cancer	0.00317	0.00317	CcSEcCtD
Sodium lauryl sulfate—Infection—Cisplatin—bone cancer	0.00315	0.00315	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Doxorubicin—bone cancer	0.00313	0.00313	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Epirubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Cisplatin—bone cancer	0.00309	0.00309	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Epirubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Cisplatin—bone cancer	0.00306	0.00306	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Cisplatin—bone cancer	0.00302	0.00302	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Cisplatin—bone cancer	0.00296	0.00296	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Cisplatin—bone cancer	0.00285	0.00285	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Cisplatin—bone cancer	0.00283	0.00283	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Cisplatin—bone cancer	0.00276	0.00276	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—bone cancer	0.00275	0.00275	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Methotrexate—bone cancer	0.00268	0.00268	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—bone cancer	0.00267	0.00267	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Cisplatin—bone cancer	0.00251	0.00251	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Cisplatin—bone cancer	0.00234	0.00234	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Cisplatin—bone cancer	0.00227	0.00227	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Cisplatin—bone cancer	0.00217	0.00217	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—bone cancer	0.00211	0.00211	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Methotrexate—bone cancer	0.00209	0.00209	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Cisplatin—bone cancer	0.00202	0.00202	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Methotrexate—bone cancer	0.00201	0.00201	CcSEcCtD
Sodium lauryl sulfate—Rash—Cisplatin—bone cancer	0.002	0.002	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Cisplatin—bone cancer	0.002	0.002	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Sodium lauryl sulfate—Nausea—Cisplatin—bone cancer	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Methotrexate—bone cancer	0.00181	0.00181	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—bone cancer	0.00175	0.00175	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Sodium lauryl sulfate—Infection—Methotrexate—bone cancer	0.00173	0.00173	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Methotrexate—bone cancer	0.00168	0.00168	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Methotrexate—bone cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Methotrexate—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Methotrexate—bone cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Methotrexate—bone cancer	0.00128	0.00128	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Methotrexate—bone cancer	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Methotrexate—bone cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Rash—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Sodium lauryl sulfate—Headache—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Nausea—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—bone cancer	0.000996	0.000996	CcSEcCtD
Sodium lauryl sulfate—Nausea—Epirubicin—bone cancer	0.000967	0.000967	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—bone cancer	0.000958	0.000958	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—bone cancer	0.00095	0.00095	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—bone cancer	0.000949	0.000949	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—bone cancer	0.000944	0.000944	CcSEcCtD
Sodium lauryl sulfate—Nausea—Doxorubicin—bone cancer	0.000895	0.000895	CcSEcCtD
